QA: Lipocine Inc in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001535955_2022_Lipocine_Inc.pdf

Logs

Graph

Absolute values for 0001535955, Lipocine Inc

  xvar xval
0 AssetsCurrent 46,379,675
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 7,211
3 remainder_Assets 6,095,553
4 LiabilitiesCurrent 5,616,625
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 1,295,796
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 5,270,853
9 ResearchAndDevelopmentExpense 7,637,893
10 remainder_Expenses 200
11 remainder_Revenues 201,113
12 remainder_NetIncome -3,957,862
13 remainder_ComprehensiveNetIncome -10,301
  yvar yval
0 Assets 52,482,439
1 Liabilities 6,912,421
2 Expenses 12,908,946
3 Revenues 201,113
4 StockholdersEquity 45,570,018
5 NetIncome -16,665,695
6 ComprehensiveNetIncome -16,670,846
7 BaseVar 38,236,541
8 EconomicCapitalRatiobeforeLimitedLiability 2.78
9 EconomicCapitalRatio 3.54

Edgar->Model Mapping

Feature Distribution

Change over Time